Nifty
Sensex
:
:
25030.35
81028.02
493.75 (2.01%)
1718.01 (2.17%)

Pharmaceuticals & Drugs

Rating :
60/99

BSE: 524280 | NSE: KOPRAN

261.73
06-Nov-2026
  • Open
  • High
  • Low
  • Previous Close
  •  265
  •  265
  •  258.21
  •  264.77
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  178657
  •  46703886.72
  •  295.83
  •  107

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,263.49
  • 32.15
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,464.38
  • 1.15%
  • 2.39

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 41.82%
  • 5.82%
  • 46.33%
  • FII
  • DII
  • Others
  • 0.91%
  • 0.00%
  • 5.12%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.20
  • 7.37
  • 3.50

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.54
  • -6.62
  • -3.59

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.60
  • -15.86
  • -20.37

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.07
  • 24.20
  • 28.02

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.02
  • 2.21
  • 2.05

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.62
  • 14.62
  • 15.60

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 26
Sep 25
Var%
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Net Sales
211.26
117.91
79.17%
153.99
135.22
13.88%
234.02
172.36
35.77%
194.28
166.24
16.87%
Expenses
195.85
123.19
58.98%
138.19
121.09
14.12%
201.07
155.28
29.49%
176.52
146.40
20.57%
EBITDA
15.41
-5.28
-
15.80
14.13
11.82%
32.94
17.09
92.74%
17.76
19.84
-10.48%
EBIDTM
7.30%
-4.48%
10.26%
10.45%
14.08%
9.91%
9.14%
11.93%
Other Income
0.62
0.03
1,966.67%
2.05
2.56
-19.92%
0.09
3.26
-97.24%
0.07
0.17
-58.82%
Interest
4.25
2.09
103.35%
3.28
2.54
29.13%
3.17
2.77
14.44%
2.67
2.16
23.61%
Depreciation
5.89
4.28
37.62%
5.77
4.26
35.45%
4.52
3.87
16.80%
4.42
4.00
10.50%
PBT
5.89
-11.63
-
8.80
9.89
-11.02%
25.35
13.71
84.90%
10.75
13.86
-22.44%
Tax
1.50
-1.70
-
2.10
2.44
-13.93%
6.48
4.03
60.79%
1.41
3.46
-59.25%
PAT
4.40
-9.92
-
6.70
7.45
-10.07%
18.87
9.68
94.94%
9.34
10.39
-10.11%
PATM
2.08%
-8.42%
4.35%
5.51%
8.06%
5.61%
4.81%
6.25%
EPS
0.91
-2.06
-
1.39
1.54
-9.74%
3.91
2.00
95.50%
1.93
2.15
-10.23%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
793.55
681.42
629.60
614.59
550.99
477.52
491.81
359.50
357.90
313.32
309.72
Net Sales Growth
34.11%
8.23%
2.44%
11.54%
15.39%
-2.91%
36.80%
0.45%
14.23%
1.16%
 
Cost Of Goods Sold
510.28
411.39
376.08
374.40
334.49
248.55
283.34
192.78
190.88
171.87
164.89
Gross Profit
283.27
270.04
253.52
240.19
216.50
228.97
208.47
166.72
167.02
141.44
144.82
GP Margin
35.70%
39.63%
40.27%
39.08%
39.29%
47.95%
42.39%
46.38%
46.67%
45.14%
46.76%
Total Expenditure
711.63
619.47
556.70
540.23
499.19
390.28
410.20
312.80
312.47
284.27
273.60
Power & Fuel Cost
-
29.07
26.45
24.52
23.16
19.27
16.65
18.08
17.10
14.90
13.71
% Of Sales
-
4.27%
4.20%
3.99%
4.20%
4.04%
3.39%
5.03%
4.78%
4.76%
4.43%
Employee Cost
-
65.21
60.54
52.28
49.95
43.27
37.16
36.85
37.11
32.24
31.37
% Of Sales
-
9.57%
9.62%
8.51%
9.07%
9.06%
7.56%
10.25%
10.37%
10.29%
10.13%
Manufacturing Exp.
-
48.50
47.13
45.34
42.67
38.78
33.89
30.06
32.41
31.35
31.84
% Of Sales
-
7.12%
7.49%
7.38%
7.74%
8.12%
6.89%
8.36%
9.06%
10.01%
10.28%
General & Admin Exp.
-
33.25
32.28
29.56
27.86
28.23
26.35
20.99
18.92
19.20
16.93
% Of Sales
-
4.88%
5.13%
4.81%
5.06%
5.91%
5.36%
5.84%
5.29%
6.13%
5.47%
Selling & Distn. Exp.
-
10.86
8.81
9.40
9.31
8.54
8.42
9.36
9.18
9.56
8.46
% Of Sales
-
1.59%
1.40%
1.53%
1.69%
1.79%
1.71%
2.60%
2.56%
3.05%
2.73%
Miscellaneous Exp.
-
21.19
5.43
4.72
11.77
3.64
4.40
4.69
6.86
5.15
8.46
% Of Sales
-
3.11%
0.86%
0.77%
2.14%
0.76%
0.89%
1.30%
1.92%
1.64%
2.06%
EBITDA
81.91
61.95
72.90
74.36
51.80
87.24
81.61
46.70
45.43
29.05
36.12
EBITDA Margin
10.32%
9.09%
11.58%
12.10%
9.40%
18.27%
16.59%
12.99%
12.69%
9.27%
11.66%
Other Income
2.83
0.35
3.98
14.67
3.06
10.76
18.15
0.63
3.96
10.94
10.66
Interest
13.37
10.47
9.34
8.59
6.08
5.12
6.24
8.91
8.99
8.60
13.70
Depreciation
20.60
17.47
15.59
12.89
12.71
11.10
10.19
9.58
8.74
8.51
8.33
PBT
50.79
34.36
51.95
67.54
36.07
81.78
83.34
28.84
31.66
22.89
24.76
Tax
11.49
8.63
13.40
16.59
8.83
20.75
21.73
7.26
7.64
2.40
4.85
Tax Rate
22.62%
25.12%
25.79%
24.56%
24.48%
25.37%
26.07%
25.66%
24.13%
10.48%
19.59%
PAT
39.31
25.73
38.55
50.96
27.23
61.03
61.61
21.02
24.02
20.49
19.91
PAT before Minority Interest
39.31
25.73
38.55
50.96
27.23
61.03
61.61
21.02
24.02
20.49
19.91
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
4.95%
3.78%
6.12%
8.29%
4.94%
12.78%
12.53%
5.85%
6.71%
6.54%
6.43%
PAT Growth
123.35%
-33.26%
-24.35%
87.15%
-55.38%
-0.94%
193.10%
-12.49%
17.23%
2.91%
 
EPS
8.14
5.33
7.98
10.55
5.64
12.64
12.76
4.35
4.97
4.24
4.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
530.28
518.35
491.25
439.25
426.17
245.03
189.68
168.48
144.71
124.67
Share Capital
48.29
48.29
48.21
48.21
48.21
43.25
43.25
43.25
43.25
43.25
Total Reserves
480.62
468.45
442.00
391.04
377.96
201.78
146.43
125.23
101.46
81.42
Non-Current Liabilities
31.90
36.70
33.47
33.48
33.13
33.67
40.48
46.17
31.45
32.17
Secured Loans
1.37
2.04
0.45
0.65
0.15
0.33
0.15
0.28
0.44
0.33
Unsecured Loans
12.58
14.45
16.16
17.24
18.62
20.88
31.68
40.84
29.48
32.17
Long Term Provisions
8.94
10.89
9.00
8.51
8.09
7.47
7.20
6.42
5.14
4.59
Current Liabilities
346.18
288.97
218.53
176.97
151.59
160.68
140.05
134.71
135.53
136.49
Trade Payables
157.82
119.41
113.09
87.38
62.30
85.91
54.74
51.16
60.67
47.13
Other Current Liabilities
47.38
38.86
22.80
32.85
31.40
28.85
38.17
35.24
21.30
29.91
Short Term Borrowings
136.51
129.06
81.02
55.51
53.71
43.08
46.23
45.44
52.11
56.09
Short Term Provisions
4.47
1.63
1.63
1.23
4.17
2.84
0.91
2.87
1.45
3.36
Total Liabilities
908.36
844.02
743.25
649.70
610.89
439.38
370.21
349.36
311.69
293.33
Net Block
346.45
208.41
181.71
164.99
150.69
112.19
111.15
112.62
104.44
104.47
Gross Block
460.65
305.55
263.45
233.83
206.81
157.31
146.31
138.14
121.27
112.80
Accumulated Depreciation
114.20
97.14
81.74
68.84
56.12
45.12
35.16
25.52
16.84
8.33
Non Current Assets
385.19
334.26
289.22
250.63
196.01
162.43
147.61
141.79
118.20
113.62
Capital Work in Progress
24.79
113.20
96.59
69.58
35.55
42.89
30.24
24.29
9.93
6.29
Non Current Investment
0.06
0.06
0.06
0.06
0.06
0.05
0.02
0.02
0.05
0.05
Long Term Loans & Adv.
12.57
11.03
9.11
14.33
8.19
6.09
4.90
3.54
2.47
2.30
Other Non Current Assets
1.32
1.57
1.75
1.67
1.53
1.22
1.29
1.32
1.31
0.50
Current Assets
523.18
509.75
454.03
399.07
414.87
276.95
222.60
207.57
193.50
179.72
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
164.21
169.42
138.49
130.61
149.94
100.00
88.50
73.45
71.01
60.56
Sundry Debtors
262.66
214.93
212.33
162.56
127.36
120.08
92.81
86.64
64.77
73.11
Cash & Bank
7.22
25.86
14.20
12.58
57.13
6.90
4.75
3.96
6.18
6.88
Other Current Assets
89.09
4.99
6.32
5.77
80.44
49.97
36.55
43.52
51.54
39.16
Short Term Loans & Adv.
83.95
94.54
82.70
87.55
75.55
44.14
34.26
37.98
47.57
37.33
Net Current Assets
177.00
220.78
235.50
222.10
263.29
116.26
82.55
72.85
57.96
43.23
Total Assets
908.37
844.01
743.25
649.70
610.88
439.38
370.21
349.36
311.70
293.34

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
66.75
41.94
43.26
34.02
-33.48
59.95
31.00
25.41
25.77
15.87
PBT
34.36
51.95
67.54
36.07
81.78
83.34
28.84
31.66
22.89
24.76
Adjustment
25.81
24.80
20.96
16.29
13.82
16.44
21.63
13.35
13.52
25.15
Changes in Working Capital
12.33
-21.56
-30.91
-5.55
-110.81
-23.79
-11.77
-15.72
-7.56
-33.13
Cash after chg. in Working capital
72.50
55.19
57.59
46.81
-15.21
75.98
38.70
29.30
28.84
16.78
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-5.75
-13.25
-14.33
-12.79
-18.27
-16.03
-7.15
-3.88
-3.07
-0.91
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
-0.55
0.00
0.00
0.00
Cash From Investing Activity
-64.60
-56.43
-43.55
-12.65
-84.42
-25.28
-12.52
-24.86
-10.96
-17.96
Net Fixed Assets
-25.10
-16.95
-10.46
-5.97
-3.31
-4.35
-4.86
-5.66
-5.43
35.65
Net Investments
-1.49
-1.80
-1.20
-0.64
-100.64
-0.65
-0.62
-0.60
-0.32
-0.53
Others
-38.01
-37.68
-31.89
-6.04
19.53
-20.28
-7.04
-18.60
-5.21
-53.08
Cash from Financing Activity
-20.94
25.87
0.99
-19.84
122.82
-34.57
-18.06
-0.58
-15.02
1.97
Net Cash Inflow / Outflow
-18.79
11.38
0.69
1.53
4.93
0.10
0.42
-0.03
-0.21
-0.12
Opening Cash & Equivalents
19.47
8.09
7.40
5.87
0.94
0.83
0.41
0.44
0.66
0.78
Closing Cash & Equivalent
0.68
19.47
8.09
7.40
5.87
0.94
0.83
0.41
0.44
0.66

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
109.54
107.02
101.68
91.11
88.40
56.65
43.86
38.95
33.46
28.83
ROA
2.94%
4.86%
7.32%
4.32%
11.62%
15.22%
5.84%
7.27%
6.77%
7.15%
ROE
4.92%
7.66%
10.96%
6.29%
18.19%
28.34%
11.74%
15.34%
15.21%
17.71%
ROCE
6.65%
9.75%
13.78%
8.30%
21.40%
30.40%
13.69%
16.30%
13.88%
19.24%
Fixed Asset Turnover
1.78
2.21
2.47
2.53
2.66
3.30
2.54
2.76
2.69
1.49
Receivable days
127.91
123.83
111.32
94.82
93.20
77.53
90.59
77.21
79.96
74.44
Inventory Days
89.35
89.24
79.90
91.76
94.14
68.65
81.75
73.66
76.30
68.37
Payable days
122.98
112.82
97.72
81.67
108.83
90.60
60.78
68.76
72.54
73.61
Cash Conversion Cycle
94.28
100.24
93.50
104.91
78.51
55.58
111.55
82.11
83.72
69.21
Total Debt/Equity
0.29
0.29
0.20
0.17
0.17
0.27
0.47
0.58
0.61
0.76
Interest Cover
4.28
6.56
8.86
6.93
16.98
14.36
4.17
4.52
3.66
2.81

News Update:


  • Kopran - Quarterly Results
    4th Nov 2026, 00:00 AM

    Read More
  • Kopran concludes EU GMP inspection of Khopoli facility
    22nd Oct 2026, 16:21 PM

    The inspection was conducted from September 18, 2026 to September 23, 2026

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.